Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitisTamás Tornai, Mária Papp, Eszter Pályu et al.|World Journal of Gastroenterology|2017Cited by 48
Deleterious effect of proton pump inhibitors on the disease course of cirrhosisTamás Janka, Zsuzsanna Vitális, Tamás Tornai et al.|European Journal of Gastroenterology & Hepatology|2019Cited by 37
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitisTamás Tornai, Mária Papp, Dávid Tornai et al.|Scientific Reports|2018Cited by 31
Macrophage activation marker, soluble <scp>CD</scp>163, is an independent predictor of short‐term mortality in patients with cirrhosis and bacterial infectionTamás Tornai, Mária Papp, Zsuzsanna Vitális et al.|Liver International|2016Cited by 27
Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosisMária Papp, Péter Antal‐Szalmás, Tamás Tornai et al.|World Journal of Gastroenterology|2016Cited by 27